Copyright
©The Author(s) 2016.
World J Gastroenterol. Nov 7, 2016; 22(41): 9172-9185
Published online Nov 7, 2016. doi: 10.3748/wjg.v22.i41.9172
Published online Nov 7, 2016. doi: 10.3748/wjg.v22.i41.9172
Ref. | Year | Journal | Population | n | Outcome | Measure | Value |
C-reactive protein | |||||||
Reuken et al[72] | 2013 | Liver Int | Ascites | 108 | 90-d mortality | AUC | 0.69 (0.59-0.79), P = 0.001 |
Moreno et al[69] | 2013 | Liver Int | Non-septic | 95 | 1-yr mortality | AUC | 0.71 (0.6-0.8), P < 0.001 |
Mortensen et al[70] | 2012 | Eur J Gastroenterol Hepatol | Stable alcohol cirrhosis | 45 | Long term mortality (about 6- yr) | HR1 | |
1.074 (1.001-1.153), P = 0.046 | |||||||
Wiese et al[74] | 2014 | Liver Int | Stable cirrhotic | 193 | 1- yr survival | HR | 1.18, P = 0.0483 |
Lim et al[68] | 2014 | Plos One | SBP | 75 | 30-d mortality | AUC | 0.64 (0.49-0.79), P = 0.076 |
HR | ND, P = 0.064 | ||||||
Schwabl et al[73] | 2015 | Liver Int | SBP | 168 | 30-d mortality | HR1 | 1.067 (1.004-1.134), P = 0.037 |
Ha et al[65] | 2011 | Korean J Intern Med | Bacteraemia | 202 | 30-d mortality | Difference | Survivor vs non-survivor2 |
37.8 vs 34.3 mg/L, P = 0.721 | |||||||
Cervoni et al[20] | 2012 | J Hepatol | CPs > 7 | 148 | 180-d mortality | AUC | 0.63 (0.51-0.73), P = ND |
HR14 | 2.73 (1.41-5.26), P = 0.003 | ||||||
Di Martino et al[64] | 2015 | Liver Transplant | CPs > 7 | 109 | 90-d mortality | HR14 | 2.21 (1.03-4.76), P = 0.042 |
Cervoni et al[63] | 2016 | Eur J Gastroenterol Hepatol | CPs > 7 | 583 | 90-d mortality | HR14 | 1.69 (1.01-2.81), P = 0.046 |
Park et al[71] | 2015 | J Korean Med Sci | Alcoholic cirrhosis various reasons for admission | 409 | 30-d mortality | OR | "CRP > 20 not independent predictor" |
Ximenes et al[75] | 2016 | Am J Emerg Med | Hepatic decompensation | 149 | Inhospital mortality | OR | OR: ND, P > 0.100 |
Kwon et al[67] | 2015 | BMC Gastroenterol | Acute decompensation | 184 | 30 d survival | OR | OR: ND, P = 0.122 |
Lazzarotto et al[19] | 2013 | Ann Hepatol | Acute decompensation | 64 | 90 d survival | Difference | Survivor vs non-survivor2 |
7 vs 41 mg/L, P = 0.026 | |||||||
Kronenberger et al[66] | 2012 | BMC Med | Acute decompensation + outpatients | 120 | Overall survival (196 ± 165 d) | HR | Univariate: 0.314 (0.141-0.702) , P = 0.005 |
Multivariate: ND, P = 0.077 | |||||||
Procalcitonin | |||||||
Lin et al[80] | 2015 | J Crit Care | Acute decompensation | 96 | Sepsis in-hospital mortality | AUC | 0.692 |
Kotecha et al[79] | 2013 | Eur J Gastroenterol Hepatol | Cirrhosis + SIRS | 100 | In-hospital survival | OR1 | 0.949 (0.868-1.037), P = 0.249 |
Connert et al[78] | 2003 | Z Gastroenterol | Compensated + decompensated | 100 | 60-d mortality | Percent died | < 0.58 vs≥ 0.58: |
9.1% vs 46.7%, P < 0.001 | |||||||
Al-Dorzi et al[76] | 2014 | Clin Lab | Septic shock | 45 | 28-d mortality | Difference | Low PCT vs high PCT: |
80% vs 77%, P = 0.61 | |||||||
Berres et al[77] | 2009 | Liver Int | Critically ill | 38 | ICU mortality | Difference | NA, P = NS |
- Citation: Papp M, Tornai T, Vitalis Z, Tornai I, Tornai D, Dinya T, Sumegi A, Antal-Szalmas P. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. World J Gastroenterol 2016; 22(41): 9172-9185
- URL: https://www.wjgnet.com/1007-9327/full/v22/i41/9172.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i41.9172